ロード中...
Results of a phase Ib trial of combination immunotherapy with a CD8+ T cell eliciting vaccine and trastuzumab in breast cancer patients
BACKGROUND: CD8+ T cell-eliciting vaccines are being investigated in breast cancer patients. Preclinical data showed that trastuzumab increases the susceptibility of tumor cells to lysis by vaccine-generated CD8+ T cells suggesting potential benefit of a combination immunotherapy strategy. The curre...
保存先:
| 出版年: | Ann Surg Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5908243/ https://ncbi.nlm.nih.gov/pubmed/28315060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-017-5844-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|